Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy
- 18 November 2008
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (1) , 184-191
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Endothelial dysfunction in insulin resistance and type 2 diabetesJournal of Internal Medicine, 2007
- Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary SyndromeDiabetes Care, 2007
- Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo‐controlled studyJournal of Internal Medicine, 2005
- Treatment with combined oral contraceptives induces a rise in serum C‐reactive protein in the absence of a general inflammatory responseJournal of Thrombosis and Haemostasis, 2005
- Inflammatory Markers and the Risk of Coronary Heart Disease in Men and WomenNew England Journal of Medicine, 2004
- Differential and Opposing Regulation of PAI-1 Promoter Activity by Estrogen Receptor α and Estrogen Receptor β in Endothelial CellsCirculation Research, 2004
- Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factorsJournal of Obstetrics and Gynaecology, 2004
- Estrogen Stimulates Dimethylarginine Dimethylaminohydrolase Activity and the Metabolism of Asymmetric DimethylarginineCirculation, 2003
- Altered Vascular Function in Young Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2002
- Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal womenClinical Science, 2001